VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1 +$2.49M
2 +$2.46M
3 +$2.31M
4
OXLC
Oxford Lane Capital
OXLC
+$2.19M
5
TKO icon
TKO Group
TKO
+$2.17M

Top Sells

1 +$1.99M
2 +$1.62M
3 +$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYN icon
426
Dyne Therapeutics
DYN
$3.13B
$99.5K 0.03%
7,869
+1,366
NGNE icon
427
Neurogene
NGNE
$327M
$96.7K 0.03%
5,578
+969
SLNO icon
428
Soleno Therapeutics
SLNO
$2.71B
$95.9K 0.03%
1,419
+247
AVBP icon
429
ArriVent BioPharma
AVBP
$947M
$88.9K 0.03%
4,816
+837
NRIX icon
430
Nurix Therapeutics
NRIX
$1.79B
$87.9K 0.03%
9,514
+1,652
AUTL
431
Autolus Therapeutics
AUTL
$375M
$86.3K 0.02%
52,924
+9,188
MREO
432
Mereo BioPharma
MREO
$298M
$84.3K 0.02%
40,930
+7,105
TRDA icon
433
Entrada Therapeutics
TRDA
$393M
$84.1K 0.02%
14,495
+2,516
TECX
434
Tectonic Therapeutic
TECX
$401M
$79.6K 0.02%
5,071
+881
CGEM icon
435
Cullinan Oncology
CGEM
$672M
$75.4K 0.02%
12,714
+2,208
ALT icon
436
Altimmune
ALT
$549M
$60K 0.02%
15,914
+2,763
CAPR icon
437
Capricor Therapeutics
CAPR
$245M
$58.9K 0.02%
8,163
+1,417
REPL icon
438
Replimune Group
REPL
$784M
$48.2K 0.01%
11,511
+1,998
MLTX icon
439
MoonLake Immunotherapeutics
MLTX
$973M
$18.5K 0.01%
2,585
+449
BKT.RT
440
DELISTED
BlackRock Income Trust Rights exp October 20 2025
BKT.RT
$3.46K ﹤0.01%
+58,703
AFL icon
441
Aflac
AFL
$57.8B
-12,839
BGX
442
Blackstone Long-Short Credit Income Fund
BGX
$151M
-56,944
CBRE icon
443
CBRE Group
CBRE
$48.2B
-11,480
CCIF
444
Carlyle Credit Income Fund
CCIF
$110M
-181,994
CHD icon
445
Church & Dwight Co
CHD
$20.4B
-13,956
MMC icon
446
Marsh & McLennan
MMC
$89.9B
-6,319
MPV
447
Barings Participation Investors
MPV
$216M
-28,448
MSI icon
448
Motorola Solutions
MSI
$61.6B
-3,222
NOC icon
449
Northrop Grumman
NOC
$81.7B
-2,929
NU icon
450
Nu Holdings
NU
$84.3B
-115,382